The weekend after Christmas is often one of the busiest for U.S. ski resorts, but the chairs aren’t spinning at Telluride ...

Agios upgraded after FDA approval of Aqvesme for thalassemia. Explore AGIO’s financial outlook, upside potential, and future ...

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...

Sanofi's Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address the underlying causes of ITP ...

Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the U.S. launch of the next generation LifeVest® wearable cardioverter defibrillator (WCD).

The Parliament has passed the new VB-G RAM G Bill that will replace the 20-year-old MGNREGA on Thursday. The bill was passed ...

A Phase 1b trial shows the higher dose of pociredir boosts fetal hemoglobin levels in adults with sickle cell disease.

NGOs laud NASS over Sickle Cell Centres Bill, bankroll free clinic for 400 warriors The CrimsonBow Sickle Cell Initiative and Rabiu Olowo Foundation have applauded the Senate for prioritising the ...

The CrimsonBow Sickle Cell Initiative has applauded the Senate for prioritising the welfare of persons living with Sickle ...